MedTrace Logo

Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

NCT06935968 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-04-20

No results posted yet for this study

Summary

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Conditions

  • Hemoglobin; Deficiency

Interventions

DEVICE

Levonorgestrel intrautrine system

Insertion of levonorgestrel intrautrine system and take a blood sample from the women to analyse it

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-05-31
Completion
2026-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06935968 on ClinicalTrials.gov